MONEY

Goldman Sachs reiterates Buy on 4D Molecular Therapeutics, highlights promising gene therapy results

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 20, 2024 - 00:00
Goldman Sachs reiterates Buy on 4D Molecular Therapeutics, highlights promising gene therapy results
Read More

Tags:

Previous Article

Workday shares see price target increase, with potential outperformance in FINS ...

Next Article

AppLovin stock remains a Buy as Citi raises target, citing confidence in softwar...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

What the Fed decision means for markets, beyond the near term

What the Fed decision means for markets, beyond the nea...

Tomas Kauer - Mode... Sep 23, 2024

KinderCare valued at about $3.1 billion as shares jump in strong NYSE debut

KinderCare valued at about $3.1 billion as shares jump ...

Tomas Kauer - Mode... Oct 10, 2024

DA Davidson reaffirms Buy rating on Zeta Global stock after positive client feedback at ZETA Live 2024

DA Davidson reaffirms Buy rating on Zeta Global stock a...

Tomas Kauer - Mode... Sep 29, 2024